Yazar "Cicin, İrfan" için listeleme
-
Breast, ovarian and other site cancer patients with BRCA 1/2 mutations: Data from Turkish multicenter retrospective study
Köstek, O.; Kücükarda, Ahmet; Tozkır, Hilmi; Nihat Okten, I.; Özden, E.; Çabuk, D.; Cicin, İrfan (Zerbinis Publications, 2021)Purpose: To demonstrate the clinical and demographic findings of the patients harboring BRCA1/2 mutations with breast, genital tract, prostate and pancreas cancers. Methods: The results of sequencing analysis of 200 cancer ... -
Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey
Kilickap, S.; Öztürk, A.; Karadurmuş, N.; Korkmaz, T.; Yumuk, P.; Cicin, İrfan; Tunali, D.; Yetişyiğit, Tarkan (Elsevier Science Inc, 2018)[No Abstract Available] -
Genetic screening results of individuals with high risk BRCA-related breast/ovarian cancer in Trakya region of Turkey
Demir, Selma; Tozkır, Hilmi; Gürkan, Hakan; Atli, E. Ikbal; Yalçıntepe, Sinem; Atli, Engin; Cicin, İrfan (Imprimatur Publications, 2020)Purpose: Pathogenic/likely pathogenic (P/LP) germline variations in BRCA1 and BRCA2 genes are responsible for the majority of hereditary breast and ovarian cancers. This study presents the BRCA1/BRCA2 sequencing and deletion ... -
Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey
Kilickap, S.; Demirci, U.; Buğdaycı, F.; Tural, D.; Korkmaz, T.; Paydas, S.; Cicin, İrfan; Seber, Selçuk (Elsevier Science Inc, 2019)[No Abstract Available]